Superstring Capital Management LP Century Therapeutics, Inc. Transaction History
Superstring Capital Management LP
- $84.5 Billion
- Q2 2025
A detailed history of Superstring Capital Management LP transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 462,963 shares of IPSC stock, worth $240,740. This represents 0.31% of its overall portfolio holdings.
Number of Shares
462,963
Previous 462,963
-0.0%
Holding current value
$240,740
Previous $220 Million
17.37%
% of portfolio
0.31%
Previous 0.26%
Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
63Shares Held
23.3MCall Options Held
33.4KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$2.81 Million0.91% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$1.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.02MShares$1.05 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$886,2000.28% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $30.6M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...